Preferred Label : Galactosialidosis;
Symbol : GSL;
CISMeF acronym : GSL; NGBE;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Goldberg syndrome; Neuraminidase/beta-galactosidase expression; Lysosomal protective protein deficiency; NGBE; Neuraminidase deficiency with beta-galactosidase deficiency; Protective protein/cathepsin a deficiency; Ppca deficiency; Cathepsin a deficiency;
Description : Galactosialidosis is a lysosomal storage disease associated with a combined deficiency
of beta-galactosidase (611458) and neuraminidase (608272), secondary to a defect in
protective protein/cathepsin A (PPCA). All patients have clinical manifestations typical
of a lysosomal disorder, such as coarse facies, cherry red spots, vertebral changes,
foam cells in the bone marrow, and vacuolated lymphocytes. Three phenotypic subtypes
are recognized. The early infantile form is associated with fetal hydrops, edema,
ascites, visceromegaly, skeletal dysplasia, and early death. The late infantile type
is characterized by hepatosplenomegaly, growth retardation, cardiac involvement, and
rare occurrence of neurologic signs. The juvenile/adult form is characterized by myoclonus,
ataxia, angiokeratoma, mental retardation, neurologic deterioration, absence of visceromegaly,
and long survival. The majority of reported patients belong to the juvenile/adult
group and are mainly of Japanese origin (summary by d'Azzo et al., 2001).;
Inheritance : Autosomal recessive;
Prefixed ID : #256540;
Origin ID : 256540;
UMLS CUI : C0268233;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)